Algert Global LLC Avidity Biosciences, Inc. Transaction History
Algert Global LLC
- $3.72 Billion
- Q3 2024
A detailed history of Algert Global LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Algert Global LLC holds 38,253 shares of RNA stock, worth $1.28 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
38,253
Previous 42,563
10.13%
Holding current value
$1.28 Million
Previous $1.74 Million
1.04%
% of portfolio
0.05%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding RNA
# of Institutions
250Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$355 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$308 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$287 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$271 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$234 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.74B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...